Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 2012; Volume 82,Issue 3

Articles

  • You have access
    New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors
    Kenneth A. Jacobson and Stefano Costanzi
    Molecular Pharmacology September 2012, 82 (3) 361-371; DOI: https://doi.org/10.1124/mol.112.079335
  • You have access
    Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells
    Zoltan Varga, Georgina Gurrola-Briones, Ferenc Papp, Ricardo C. Rodríguez de la Vega, Gustavo Pedraza-Alva, Rajeev B. Tajhya, Rezso Gaspar, Luis Cardenas, Yvonne Rosenstein, Christine Beeton, Lourival D. Possani and Gyorgy Panyi
    Molecular Pharmacology September 2012, 82 (3) 372-382; DOI: https://doi.org/10.1124/mol.112.078006
  • You have access
    Carbonylation Induces Heterogeneity in Cardiac Ryanodine Receptor Function in Diabetes Mellitus
    Chun Hong Shao, Chengju Tian, Shouqiang Ouyang, Caronda J. Moore, Fadhel Alomar, Ina Nemet, Alicia D'Souza, Ryoji Nagai, Shelby Kutty, George J. Rozanski, Sasanka Ramanadham, Jaipaul Singh and Keshore R. Bidasee
    Molecular Pharmacology September 2012, 82 (3) 383-399; DOI: https://doi.org/10.1124/mol.112.078352
  • You have access
    A New 2-Pyrone Derivative, 5-Bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, Suppresses Stemness in Glioma Stem-Like Cells
    Rae-Kwon Kim, Min-Jung Kim, Chang-Hwan Yoon, Eun-Jung Lim, Ki-Chun Yoo, Ga-Haeng Lee, Young-Heon Kim, Hyeonmi Kim, Yeung Bae Jin, Yoon-Jin Lee, Cheon-Gyu Cho, Yeong Seok Oh, Myung Chan Gye, Yongjoon Suh and Su-Jae Lee
    Molecular Pharmacology September 2012, 82 (3) 400-407; DOI: https://doi.org/10.1124/mol.112.078402
  • You have access
    Neurosteroid Analog Photolabeling of a Site in the Third Transmembrane Domain of the β3 Subunit of the GABAA Receptor
    Zi-Wei Chen, Brad Manion, R. Reid Townsend, David E. Reichert, Douglas F. Covey, Joe Henry Steinbach, Werner Sieghart, Karoline Fuchs and Alex S. Evers
    Molecular Pharmacology September 2012, 82 (3) 408-419; DOI: https://doi.org/10.1124/mol.112.078410
  • You have access
    Tetrahydrobiopterin Protects Soluble Guanylate Cyclase against Oxidative Inactivation
    Kurt Schmidt, Andrea Neubauer, Bernd Kolesnik, Johannes-Peter Stasch, Ernst R. Werner, Antonius C. F. Gorren and Bernd Mayer
    Molecular Pharmacology September 2012, 82 (3) 420-427; DOI: https://doi.org/10.1124/mol.112.079855
  • You have access
    Long QT2 Mutation on the Kv11.1 Ion Channel Inhibits Current Activity by Ablating a Protein Kinase Cα Consensus Site
    Alexander J. Donovan, Katherine Lansu, Jason G. Williams, Mitchell F. Denning and Saverio Gentile
    Molecular Pharmacology September 2012, 82 (3) 428-437; DOI: https://doi.org/10.1124/mol.112.077966
  • You have access
    Functional and Pharmacological Characteristics of Metabotropic Glutamate Receptors 2/4 Heterodimers
    Paul J. Kammermeier
    Molecular Pharmacology September 2012, 82 (3) 438-447; DOI: https://doi.org/10.1124/mol.112.078501
  • You have access
    Computational and Experimental Analysis of the Transmembrane Domain 4/5 Dimerization Interface of the Serotonin 5-HT1A Receptor
    Nataliya Gorinski, Noga Kowalsman, Ute Renner, Alexander Wirth, Michael T. Reinartz, Roland Seifert, Andre Zeug, Evgeni Ponimaskin and Masha Y. Niv
    Molecular Pharmacology September 2012, 82 (3) 448-463; DOI: https://doi.org/10.1124/mol.112.079137
  • You have access
    Optical Recording Reveals Novel Properties of GSK1016790A-Induced Vanilloid Transient Receptor Potential Channel TRPV4 Activity in Primary Human Endothelial Cells
    Michelle N. Sullivan, Michael Francis, Natalie L. Pitts, Mark S. Taylor and Scott Earley
    Molecular Pharmacology September 2012, 82 (3) 464-472; DOI: https://doi.org/10.1124/mol.112.078584
  • You have access
    Prolonged Stimulation of μ-Opioid Receptors Produces β-Arrestin-2-Mediated Heterologous Desensitization of α2-Adrenoceptor Function in Locus Ceruleus Neurons
    Vu C. Dang, Billy C. Chieng and MacDonald J. Christie
    Molecular Pharmacology September 2012, 82 (3) 473-480; DOI: https://doi.org/10.1124/mol.112.079350
  • You have access
    Common Mechanisms of Drug Interactions with Sodium and T-Type Calcium Channels
    Chris Bladen and Gerald W. Zamponi
    Molecular Pharmacology September 2012, 82 (3) 481-487; DOI: https://doi.org/10.1124/mol.112.079715
  • You have access
    Casein Kinase 2α Regulates Multidrug Resistance-Associated Protein 1 Function via Phosphorylation of Thr249
    Elzbieta I. Stolarczyk, Cassandra J. Reiling, Kerry A. Pickin, Ryan Coppage, Marc R. Knecht and Christian M. Paumi
    Molecular Pharmacology September 2012, 82 (3) 488-499; DOI: https://doi.org/10.1124/mol.112.078295
  • You have access
    Cardiotonic Steroids Stabilize Regulator of G Protein Signaling 2 Protein Levels
    Benita Sjögren, Sergio Parra, Lauren J. Heath, Kevin B. Atkins, Zie-Jian Xie and Richard R. Neubig
    Molecular Pharmacology September 2012, 82 (3) 500-509; DOI: https://doi.org/10.1124/mol.112.079293
  • You have access
    Sec61β Controls Sensitivity to Platinum-Containing Chemotherapeutic Agents through Modulation of the Copper-Transporting ATPase ATP7A
    Paolo B. Abada, Christopher A. Larson, Gerald Manorek, Preston Adams and Stephen B. Howell
    Molecular Pharmacology September 2012, 82 (3) 510-520; DOI: https://doi.org/10.1124/mol.112.079822
  • You have access
    Transcriptome Analysis and In Vivo Activity of Fluvastatin versus Zoledronic Acid in a Murine Breast Cancer Metastasis Model
    Nadejda Vintonenko, Jean-Philippe Jais, Nadim Kassis, Mohamed Abdelkarim, Gerard-Yves Perret, Marc Lecouvey, Michel Crepin and Melanie Di Benedetto
    Molecular Pharmacology September 2012, 82 (3) 521-528; DOI: https://doi.org/10.1124/mol.111.077248
  • You have access
    Human CYP2C8 Is Post-Transcriptionally Regulated by MicroRNAs 103 and 107 in Human Liver
    Shu-Yun Zhang, Sailesh Surapureddi, Sherry Coulter, Stephen S. Ferguson and Joyce A. Goldstein
    Molecular Pharmacology September 2012, 82 (3) 529-540; DOI: https://doi.org/10.1124/mol.112.078386
  • You have access
    Calcium Channel Blockers Act through Nuclear Factor Y to Control Transcription of Key Cardiac Genes
    Hyunjoo Cha-Molstad, Guanlan Xu, Junqin Chen, Gu Jing, Martin E. Young, John C. Chatham and Anath Shalev
    Molecular Pharmacology September 2012, 82 (3) 541-549; DOI: https://doi.org/10.1124/mol.112.078253
  • You have access
    Contribution of Subunits to Caenorhabditis elegans Levamisole-Sensitive Nicotinic Receptor Function
    Guillermina Hernando, Ignacio Bergé, Diego Rayes and Cecilia Bouzat
    Molecular Pharmacology September 2012, 82 (3) 550-560; DOI: https://doi.org/10.1124/mol.112.079962

Erratum

  • You have access
    Correction to “Rimonabant, a Cannabinoid Receptor Type 1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating Liver Kinase B1 and AMP-Activated Protein Kinase Axis Downstream of Gαi/o Inhibition”
    Molecular Pharmacology September 2012, 82 (3) 561-562; DOI: https://doi.org/10.1124/mol.82.3.561
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 82 (3)
Molecular Pharmacology
Vol. 82, Issue 3
1 Sep 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics